AI Article Synopsis

  • The Japanese Society of Nuclear Medicine released guidelines specifically for pediatric nuclear medicine to ensure safe and effective practices.* -
  • The guidelines consist of two parts: the first focuses on optimizing radiation doses for children during nuclear medicine studies.* -
  • The second part covers imaging techniques tailored to meet the unique needs of pediatric patients in nuclear medicine procedures.*

Article Abstract

The Japanese Society of Nuclear Medicine has recently published the consensus guidelines for pediatric nuclear medicine. This article is the English version of the guidelines. Part 1 proposes the dose optimization in pediatric nuclear medicine studies. Part 2 comprehensively discusses imaging techniques for the appropriate conduct of pediatric nuclear medicine procedures, considering the characteristics of imaging in children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061477PMC
http://dx.doi.org/10.1007/s12149-014-0826-9DOI Listing

Publication Analysis

Top Keywords

nuclear medicine
24
pediatric nuclear
20
consensus guidelines
8
guidelines pediatric
8
pediatric
7
nuclear
6
medicine
6
japanese consensus
4
medicine pediatric
4
pediatric radiopharmaceutical
4

Similar Publications

The N-acetyltransferase 10 inhibitor [C]remodelin: synthesis and preliminary positron emission tomography study in mice.

EJNMMI Radiopharm Chem

January 2025

Department of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.

Background: 4-(4-Cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole (remodelin) is a potent N-acetyltransferase 10 (NAT10) inhibitor. This compound inhibits tumors and weakens tumor resistance to antitumor drugs. Moreover, remodelin has been found to enhance healthspan in an animal model of the human accelerated ageing syndrome.

View Article and Find Full Text PDF

Tumor-induced osteomalacia (TIO) is a rare acquired paraneoplastic syndrome caused by a mesenchymal tumor secreting a phosphaturic hormone called FGF23. Patients present with bone pain, fragility fractures and muscle weakness. Biochemical results show hypophosphatemia, raised serum alkaline phosphatase and reduced calcitriol.

View Article and Find Full Text PDF

Purpose: To investigate the presence of tubulation in the outer nuclear layer of patients with Bietti crystalline dystrophy (BCD) using optical coherence tomography (OCT) and evaluate its relationship with visual field, visual field progression, and retinal volume.

Methods: This retrospective cross-sectional study included 37 patients diagnosed with BCD who underwent spectral-domain OCT examination. OCT examinations and Humphrey visual field tests (10-2 program) were conducted.

View Article and Find Full Text PDF

Purpose: Low-dose CT (LDCT) screening effectively reduces lung adenocarcinoma (LUAD) mortality. However, accurately evaluating the malignant potential of indeterminate lung nodules remains a challenge. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6), a potential biomarker for distinguishing benign pulmonary nodules from LUAD, may be leveraged for noninvasive positron emission tomography (PET) imaging to aid LUAD diagnosis.

View Article and Find Full Text PDF

Purpose: The loss of synaptic vesicle glycoprotein 2 A (SV2A) can lead to dysfunction of GABAergic neurons, but a direct comparison of SV2A and GABA receptor densities in humans has not been assessed. This study evaluated SV2A and GABA receptor abnormalities in patients with drug-resistant epilepsy (DRE) and compared the patterns to glucose hypometabolism.

Methods: Eleven patients with DRE were retrospectively recruited and underwent PET imaging with [F]fluorodeoxyglucose ([F]FDG), [F]Flumazenil (FMZ), and [F]SynVesT-1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!